Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple exercises during pregnancy may prevent severe birth tears

NCT ID NCT07292948

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a structured pelvic floor muscle training program during pregnancy could reduce severe tears during vaginal birth. 300 first-time mothers with low-risk pregnancies were invited to join either a supervised exercise group or receive standard care. The researchers compared rates of serious perineal injuries, episiotomies, and other birth outcomes between the two groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

300 people

The number who actually took part.

Started

Dec 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 36 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Nulliparous pregnant women aged 18 to 36 years Singleton pregnancy Gestational age of 28 weeks or greater at enrollment Low-risk pregnancy without known obstetric complications Planning a vaginal delivery Able and willing to participate in supervised exercise sessions Exclusion Criteria: * Multiple gestation Placenta previa or other contraindications to vaginal birth Preeclampsia or gestational hypertension Diabetes requiring medication History of pelvic floor or urogenital surgery Neurological disorders affecting continence or pelvic floor function Inability to attend regular training sessions Refusal to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Labor complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstetric disorder Obstetric Labor Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Harran University Research and Application Hospital

    Şanliurfa, HALİLİYE, 63300, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.